Stay updated on Pembrolizumab in MSI Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov study record page appears unchanged, with the same study information and controls visible.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.7.0 was added to the record history, replacing the previous v3.6.6 entry. This reflects a metadata update to the page rather than changes to study content.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision tag, Revision: v3.6.6, was added to the study record history. The previous Revision: v3.6.5 entry was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedThe history now shows the latest revision as v3.6.5, replacing the previous v3.6.4.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry v3.6.4 was added to the study history, replacing the previous revision v3.6.3. This updates the history record without modifying study data or results.SummaryDifference0.1%

- Check95 days agoChange DetectedThe record history gains a new revision entry v3.6.3, and the prior revision v3.6.2 is removed from the visible changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.